Relmada Therapeutics (RLMD) Earnings
|
Expand Research on RLMD
| Next EPS Date | 8/11/26 | EPS Growth Rate | +40.0% |
|---|---|---|---|
| Average EPS % Beat Rate | -1.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/26  |
Q226 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/12/26 | Q126 | -$0.22 | -$0.21 | -$0.01 | N/A | N/A | N/A |  | | Details | |
| 3/19/26 | Q425 | -$0.27 | -$0.17 | -$0.10 | N/A | N/A | N/A | | | Details | |
| 11/13/25 | Q325 | -$0.30 | -$0.45 | +$0.15 | N/A | N/A | N/A | | | Details | |
| 11/7/25 |
Q325 | N/A | -$0.45 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | N/A | -$0.45 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/7/25 | Q225 | -$0.30 | -$0.40 | +$0.10 | N/A | N/A | N/A | | | Details | |
| 5/12/25 | Q125 | -$0.58 | -$0.37 | -$0.21 | N/A | N/A | N/A | | | Details |
